Kristu Jayanti College Secures Rs 1-Crore Grant For Parkinson's Disease Research
Kristu Jayanti College, a deemed-to-be university located in Bengaluru, has secured a significant academic research grant of over Rs 1 crore. The funding was awarded under the Scheme for Promotion of Academic and Research Collaboration (SPARC), an initiative of the central education ministry.
The sanctioned funding of over Rs 1 crore will support a highly specialized scientific study focused on Parkinson's disease. The research project is titled "Development of Stimuli-Responsive Theranostic Nanocomposites of Marine- and Plant-Derived Neuroprotective Agents for Parkinson’s Disease: An Integrated Approach."
The collaborative project is scheduled for implementation over a two-year period, beginning in June 2026 and concluding in May 2028.
Shinomol George K, an assistant professor in the department of life sciences within the school of biological and forensic sciences at the university, is leading the scientific project as the principal investigator.
Dileep Francis, who serves as the dean of the centre for research and development as well as an associate professor in the department of life sciences at Kristu Jayanti College, is working on the project as the co-principal investigator.
The research is being carried out as an international partnership, with the Bengaluru-based institution collaborating directly with Sophia University, which is located in Tokyo, Japan.
The Scheme for Promotion of Academic and Research Collaboration (SPARC), which provided the grant, is a national-level initiative. The primary objective of the SPARC scheme is to enhance and strengthen India's overall research ecosystem by supporting collaborative academic and scientific endeavors between Indian and international institutions.
With this funding, the university aims to advance its research initiatives, specifically aiding the scientific investigation into how marine- and plant-derived neuroprotective agents can be developed to address the challenges of Parkinson's disease.
